logo

CLDX

Celldex Therapeutics·NASDAQ
--
--(--)
--
--(--)

CLDX fundamentals

Celldex Therapeutics (CLDX) released its earnings on Nov 10, 2025: revenue was 0 (YoY -100.00%), missed estimates; EPS was -1.01 (YoY -57.81%), missed estimates.
Revenue / YoY
0
-100.00%
EPS / YoY
-1.01
-57.81%
Report date
Nov 10, 2025

Earnings

EPS
Revenue

Revenue & Expenses

CLDX has released its 2025 Q4 earnings report, with revenue of 121.00K, reflecting a YoY change of -89.70%, and net profit of -81.32M, showing a YoY change of -72.68%. The Sankey diagram below clearly presents CLDX's revenue sources and cost distribution.

Key Indicators

Celldex Therapeutics (CLDX) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Celldex Therapeutics (CLDX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Celldex Therapeutics (CLDX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Celldex Therapeutics (CLDX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Celldex Therapeutics (CLDX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Celldex Therapeutics (CLDX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield